Scaffold Technology Market Size to Reach US$ 2.63 Billion by 2030

09 Sep 2024

Table of Content

The global scaffold technology market size was valued at US$ 1.14 billion in 2021 and it is predicted to reach around US$ 2.63 billion by 2030, poised to grow at a CAGR of 9.68% from 2022 to 2030.

Growth Factors

The tissue engineering is a broad term that refers to a variety of applications that replace and repair damaged tissue. The tissue engineering consists of three components such as scaffold, stem cells, and signaling molecules. The scaffold technology helps cells grow and develop while also providing mechanical support. Furthermore, scaffold-based platforms are utilized in 3D cell culture to change the technique by providing a surface on which the cells may really impart 3D growth. The cells are cultivated in scaffold technology within extracellular matrix and synthetic materials. The scaffold technology material qualities and scaffold parameters affect cell adhesion, activation, and proliferation.

The tremendous increase in demand for organ transplant around the world is driving the growth of the global scaffold technology market. The scaffold technology market is also being driven by an increase in the number of patients with substantial non-functioning organs. Moreover, a surge in research and development initiatives focusing on the construction of a 3D matrix based on 3D substrates is fueling the scaffold technology market expansion. The new opportunities in the scaffold technology market are also being created by advances in tissue engineering and biotechnology businesses investing in the creation of new products.

The scaffold technology enables organ implant regeneration in the treatment of injured or sick tissues and organs, while also addressing the obstacles associated with tissue culture such as vascularization. The expansion of the scaffold technology market will be aided by an increase in the number of applications. Furthermore, a surge in geriatric population which adds to the rising number of patients with non-functioning organs contributes to the growth of the scaffold technology market during the forecast period.

Future of Scaffold Technology Market

Fused deposition modelling, stereolithography, 3D printing, and selective laser sintering are all used to create scaffold technology. Due to its biocompatibility and lack of toxicity, it is used as a cellular system in tissue repair. This is one of the main reasons for the increased use of scaffold technology in drug screening and therapeutic target validation.   

Report Highlights:

• Based on the product, the hydrogels segment dominated the global scaffold technology market in 2021 with largest market share. In the foreseeable future, ongoing technological developments in hydrogel microfabrication are projected to promote the segment growth. The key market players are also introducing new hydrogels for various types of medical procedures.
• On the basis of end user, the stem cell therapy segment holds the largest market share the global scaffold technology market in 2021. The scaffold technology is increasingly being used in reconstructive surgeries, soft tissue tumor repair, aesthetic surgeries, colorectal procedures, and abdominal wall repair.
• By application, the orthopedicssegment is the largest segment in the scaffold technology market. This is due to an increase in the number of orthopedic and musculoskeletal issues.
• North America is the largest segment for scaffold technology market in terms of region. The key market players in the region are introducing new and creative products to promote the development of 3D cell culture, which is contributing to the North America region’s expansion.
• Asia-Pacific region is the fastest growing region in the scaffold technology market. The existence of government entities that undertake regenerative medicine and stem cell research has contributed to the Asia-Pacific region’s growth during the forecast period.

Scope of the Report

COVID-19 Impact Analysis:

• For biotechnology and pharmaceutical firms in the scaffold technology market, the impact of the COVID-19 epidemic is predicted to be minimal.
• The organizations have suffered a major setback as a result of lockdown restrictions, which has resulted in a decrease in manufacturing and the usage of 3D cell culture by researchers.
• However, recent advancements in stem cell therapy research and increased research and development for generating regenerative medications for COVID-19 patients are compensating for this deadly effect.   

Key Developments in the Marketplace:

• United Healthcare’s medical insurance for Vericel Corporation’s MACI were expanded in January 2021 to include coverage for people with multiple cartilage defects in the knee and cartilage problems in the patella.
• Becton, Dickinson and Company stated in July 2021 that they had finalized the acquisition of Tepha Inc, a manufacturing company specializing in resorbable polymer technology development. This acquisition will allow Becton, Dickinson and Company to expand its surgical product line and give innovative options to healthcare providers and clinicians.
• Onkos Surgical declared the launch of GenVie magnesium Bone Scaffold, a novel bone scaffold technology, in February 2020. This method is intended for axial defects that have been surgically generated as a result of a traumatic injury to the bone. 

Buy this premium research report - https://www.precedenceresearch.com/checkout/1208

Any question regarding this study, please feel free to contact at sales@precedenceresearch.com